Press Releases
Search
-
20 Oct 2004
Nine-Month Sales Up 5.6% at Constant Exchange Rates
Marcy l'Etoile, France - October 20th, 2004. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its sales for the first nine months of 2004.
-
07 Oct 2004
bioMérieux signs New Agreements with Gen-Probe
Marcy l'Etoile, France - October 7th, 2004. bioMérieux receives a $ 1 million license fee for access to its markers for blood clotting disorders. bioMérieux to give Gen-Probe an option for the access ...
-
01 Oct 2004
Appointment of an Independent Board Member - Composition of Audit and Compensation Committees
Marcy l'Etoile, France - October 1st, 2004. bioMérieux announces the nomination of a new independent Board Member, Mr Michel Angé, Vice-Président of APICIL-Prévoyance, to its Board of Directors. This ...
-
27 Sept 2004
bioMérieux innovates further in the fight against AIDS
Marcy l'Etoile, France - September 27th, 2004. A major player in the field of in vitro diagnostics, bioMérieux confirms its constant commitment to the fight against AIDS with the launch of two new adv...
-
23 Jul 2004
VIDAS® D-Dimer Exclusion™ test from bioMérieux for reliable exclusion of pulmonary embolism and deep vein thrombosis
Marcy l'Etoile, France - July 23rd, 2004. bioMérieux announces that its D-dimer assay, VIDAS D-Dimer Exclusion, is now cleared by the U.S. Food and Drug Administration (FDA) to exclude both pulmonary ...
-
21 Jul 2004
Six month report January - June 2004: Sales - in line with expectations
Marcy l'Etoile, France - July 21st, 2004. bioMérieux (Euronext : FR0010096479 – BIM) today announced: During the first six months to June 2004, bioMérieux achieved sales of Euros 461 million - an incr...